Viracta Therapeutics Inc. buy melinda
Start price
04.04.19
/
50%
€52.50
Target price
30.10.19
€70.00
Performance (%)
-63.33%
End price
30.10.19
€19.25
Summary
This prediction ended on 30.10.19 with a price of €19.25. The BUY prediction by melinda for Viracta Therapeutics Inc. performed very badly with a performance of -63.33%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Viracta Therapeutics Inc. | -2.927% | -2.927% | -68.160% | -95.802% |
iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by melinda for this prediction
In the thread Sunesis Pharmaceuticals diskutieren
SecteurRecherche biotechnologique et médicale
Nombre d'employés
: 34 personnes
Buy closed
Stopped prediction by melinda for Viracta Therapeutics Inc.
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.13
27.09.20
27.09.20
€8.75
04.11.21
04.11.21
28.57%
05.11.21
05.11.21
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.08
17.03.19
17.03.19
€52.50
04.04.19
04.04.19
102.68%
04.04.19
04.04.19
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€126.28
13.03.18
13.03.18
€232.04
13.09.18
13.09.18
-49.75%
13.09.18
13.09.18
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€767.97
30.09.13
30.09.13
€945.00
31.03.14
31.03.14
24.17%
31.03.14
31.03.14